Delivery Order SPE2DB22D3010-SPE2DB24FP2YE
Award Date
7/30/24
Potential Completion Date
7/31/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $1,885.04 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to deliver...
This is a $1,777.05 firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 3, 2025. This appears to be a component of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide 4,564,296,150 units of the prescription drug Quillivant XR (25 mg/5 ml suspension, 180 ml) at a ceiling value of $1,472.80. The contract has an ultimate completion date of April 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles. The contract has a potential value of $1,016.24 and a performance period through March 5, 2024. This delivery order is issued under Amerisourcebergen's existing indefinite delivery contract (IDC) with DLA, which has a potential...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Quillivant XR 25 mg/5 ml suspension, 150 ml. The contract has a completion date of February 6, 2024 and a potential value of $1,155.43. This delivery order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles. The delivery order, valued at $6,340.16, has a firm fixed price and a performance period through July 18, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The contract has an ultimate completion date of August 25, 2023 and a ceiling value of $1,016.24. This order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) awarded a $3,188.50 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 180 ml of Quillivant XR 25 mg/5 ml suspension. This order is part of Amerisourcebergen's $999,999,999.00 indefinite delivery contract with DLA to deliver a comprehensive range of medications and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide. The delivery...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, 60 ml, to the U.S. government. The $2,592.57 firm fixed-price contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and has an ultimate completion date of May 30, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $6,097.44 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 60 ml bottles of Quillivant XR 25 mg/5 ml oral suspension medication. The contract does not have a set-aside designation and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through...